This article was automatically generated by Dow Jones using technology from Automated Insights.
Shares of Corbus Pharmaceuticals Holdings Inc. slid 6.6% to $9.04 on what proved to be an all-around poor trading session for the stock market, with the NASDAQ Composite Index falling 1.6% to 25,873.18 and Dow Jones Industrial Average falling 0.3% to 52,498.64.
The stock's fall snapped a four-day winning streak.
Corbus Pharmaceuticals Holdings Inc. closed 56.0% below its 52-week high of $20.56, which the company achieved on October 20th.
The stock underperformed when compared to some of its peers, as Vanda Pharmaceuticals Inc. fell 3.8% to $6.00, Fortress Biotech Inc. remained unchanged, and Viking Therapeutics Inc. fell 1.90% to $38.12.
Trading volume totaled 362,228, compared to the 50-day average of 550,920.
Data source: Dow Jones Market Data, FactSet
(END) Dow Jones Newswires
July 13, 2026 16:33 ET (20:33 GMT)
Copyright (c) 2026 Dow Jones & Company, Inc.
Comments